We represented Salveo Specialty Pharmacy in its acquisition by Catamaran Corp. for $260 million in cash.

Catamaran Corp. (NASDAQ: CTRX) (TSX: CCT) is a leading provider of technology and pharmacy benefit management (PBM) services. Salveo Specialty Pharmacy is an private equity backed specialty pharmacy company headquartered in St. Petersburg, Florida with business operations in New York (Echo Salveo Specialty Pharmacy) and California (Mission Road Pharmacy).

This acquisition is subject to customary closing conditions, including the expiration or termination of the applicable waiting period under the Hart-Scott-Rodino Antitrust Improvements Act, and is expected to be completed during the fourth quarter of 2014.